{"content":"<li class=\"n-box-item date-title\" data-end=\"1481259599\" data-start=\"1481173200\" data-txt=\"Sunday, December 22, 2019\">Thursday, December  8, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3229587\" data-ts=\"1481236993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229587-microvision-declares-common-stock-offeringminus-10_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision declares common stock offering; -10.5%</a></h4><ul>\n<li>Size of the intended public offering remains undisclosed.</li>\n<li>MicroVision (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a>) shares are compounding <font color=\"red\">5% losses</font> realized in today's trade on the development.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229587\" data-linked=\"MicroVision declares common stock offering; -10.5%\" data-tweet=\"$MVIS - MicroVision declares common stock offering; -10.5% https://seekingalpha.com/news/3229587-microvision-declares-common-stock-offeringminus-10_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3229587-microvision-declares-common-stock-offeringminus-10_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229583\" data-ts=\"1481236517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229583-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a> <font color=\"green\">+3.9%</font>. <a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"green\">+3.9%</font>. <a href=\"https://seekingalpha.com/symbol/OCLR\" title=\"Oclaro, Inc.\">OCLR</a> <font color=\"green\">+2.7%</font>. <a href=\"https://seekingalpha.com/symbol/TVIX\" title=\"VelocityShares Daily 2x VIX Short-Term ETN\">TVIX</a> <font color=\"green\">+2.2%</font>. NCT <font color=\"green\">+2.0%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/XTLY\" title=\"Xactly\">XTLY</a> <font color=\"red\">-21.6%</font>. <a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a> <font color=\"red\">-17.8%</font>. <a href=\"https://seekingalpha.com/symbol/DLTH\" title=\"Duluth Holdings\">DLTH</a> <font color=\"red\">-15.0%</font>. <a href=\"https://seekingalpha.com/symbol/NCS\" title=\"NCI Building Systems Inc.\">NCS</a> <font color=\"red\">-10.6%</font>. <a href=\"https://seekingalpha.com/symbol/USAC\" title=\"USA Compression Partners, LP\">USAC</a> <font color=\"red\">-6.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229583\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AVGO $FNSR $OCLR - After Hours Gainers / Losers https://seekingalpha.com/news/3229583-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3229583-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229571\" data-ts=\"1481234228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAC\" target=\"_blank\">USAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229571-usa-compression-to-launch-4_5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Compression to launch 4.5M-share offering</a></h4><ul>\n<li>USA Compression (NYSE:<a href=\"https://seekingalpha.com/symbol/USAC\" title=\"USA Compression Partners, LP\">USAC</a>) <font color=\"red\">-6%</font> AH after announcing a public offering of 4.5M common units, with an underwriters option to purchase up to an additional 675K common units.</li>\n<li>USAC says it plans to use the proceeds to       pay down debt under its revolving credit facility and       for general partnership purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229571\" data-linked=\"USA Compression to launch 4.5M-share offering\" data-tweet=\"$USAC - USA Compression to launch 4.5M-share offering https://seekingalpha.com/news/3229571-usa-compression-to-launch-4_5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3229571-usa-compression-to-launch-4_5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229570\" data-ts=\"1481234124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZDGE\" target=\"_blank\">ZDGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229570-zedge-sees-earnings-decline-also-late-user-uptick\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zedge sees earnings decline but also late user uptick</a></h4><ul>   <li>Zedge (<a href=\"https://seekingalpha.com/symbol/ZDGE\" title=\"Zedge, Inc.\">ZDGE</a> <font color=\"red\">-2.7%</font>) has posted <a href=\"https://seekingalpha.com/news/3229555-zedge-reports-fq1-results\" target=\"_blank\">fiscal Q1 earnings</a> that saw profits and revenues decline, but the company's pointing to a late turnaround in users as a sunny sign.</li>    <li>Revenue was off 7% and direct cost of revenue rose more than 24%. Income from operations fell to $113M from the prior year's $419M.</li>    <li>Total installs rose 32.6% to 230.5M as of Oct. 31. Monthly active users got a late uptick, rising 2.6% in the last 30 days of the quarter to 31.6M.</li>    <li>With revenue slipping 6.9%, average revenue per MAU fell 10.7% to $0.0233.</li>    <li>The user uptick provides optimism, says CFO/COO Jonathan Reich: \"The increase in MAU, one of our key performance indicators, is a good harbinger for revenue expansion and we remain focused on improving this metric in coming quarters.\"</li>    <li>\n<a href=\"http://services.choruscall.com/links/zdge161205nbyzxpUE.html\" target=\"_blank\">Conference call</a> to come at 5:30 p.m. ET.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3229570\" data-linked=\"Zedge sees earnings decline but also late user uptick\" data-tweet=\"$ZDGE - Zedge sees earnings decline but also late user uptick https://seekingalpha.com/news/3229570-zedge-sees-earnings-decline-also-late-user-uptick?source=tweet\" data-url=\"https://seekingalpha.com/news/3229570-zedge-sees-earnings-decline-also-late-user-uptick\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229565\" data-ts=\"1481233582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229565-lions-gate-closes-4_4b-starz-acquisition-sets-up-new-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lions Gate closes $4.4B Starz acquisition, sets up new shares</a></h4><ul>   <li>Lions Gate Entertainment (<a href=\"https://seekingalpha.com/symbol/LGF\" target=\"_blank\">LGF</a> <font color=\"green\">+4.4%</font>) has closed on its $4.4B acquisition of Starz (<a href=\"https://seekingalpha.com/symbol/STRZA\" title=\"Starz\">STRZA</a> <font color=\"green\">+1.7%</font>) after shareholders overwhelmingly approved.</li>    <li>The cash and stock deal got an OK from 98% of Lions Gate voters and 95% of Starz voters. The companies say all closing conditions are satisfied, including regulatory approvals.</li>    <li>The result means each previous share of LGF common stock has been reclassified into a 0.5 share of voting class (NYSE:<a href=\"https://seekingalpha.com/symbol/LGF.A\" title=\"Lions Gate Entertainment Corp.\">LGF.A</a>) and 0.5 share of nonvoting class (NYSE:<a href=\"https://seekingalpha.com/symbol/LGF.B\" title=\"Lions Gate Entertainment Corp.\">LGF.B</a>). Holders of Starz series A get $18/share in cash and 0.6784 shares of LGF.B for each share.</li>    <li>Holders of Starz's series B (<a href=\"https://seekingalpha.com/symbol/STRZB\" title=\"Starz\">STRZB</a> <font color=\"green\">+4.9%</font>) get $7.26 in cash, 0.6321 shares of LGF.A and 0.6321 shares of <a href=\"https://seekingalpha.com/symbol/LGF.B\" title=\"Lions Gate Entertainment Corp.\">LGF.B</a>.</li>    <li>Existing LGF and Starz common shares will come off the NYSE and Nasdaq effective tomorrow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229565\" data-linked=\"Lions Gate closes $4.4B Starz acquisition, sets up new shares\" data-tweet=\"$LGF.A $LGF.A $LGF.B - Lions Gate closes $4.4B Starz acquisition, sets up new shares https://seekingalpha.com/news/3229565-lions-gate-closes-4_4b-starz-acquisition-sets-up-new-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3229565-lions-gate-closes-4_4b-starz-acquisition-sets-up-new-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229550\" data-ts=\"1481232406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229550-broadcomplus-2_6-earnings-report-features-beat-doubled-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom +2.6% as earnings report features beat, doubled dividend</a></h4><ul>   <li>Broadcom (<a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a> <font color=\"green\">+1.3%</font>) is <font color=\"green\">up 2.6%</font> after hours following a firm beat on profits from continuing operations, and solid guidance in <a href=\"https://seekingalpha.com/news/3229536-broadcom-beats-0_09-beats-revenue\" target=\"_blank\">fiscal Q4 results</a> where it also doubled its dividend.</li>    <li>The interim dividend was raised to $1.02/share. Net loss (including discontinued operations) was $668M, about $1.59/share. EPS from continuing operations was $3.47.</li>    <li>Net revenue by segment: Wired infrastructure, $2.07B (up 449% Y/Y; up 1% Q/Q); Wireless communications, $1.35B (up 98%; up 34% Q/Q); Enterprise storage, $561M (down 12%; up 6% Q/Q); Industrial and other, $155M (up 8%; down 21% Q/Q).</li>    <li>Cash from operations was $1.352B, and it got $200M in net cash from completing divestitures.</li>    <li>For the coming first quarter of fiscal 2017, Broadcom sees net revenue (on a non-GAAP basis) of $4B-$4.15B, above consensus for $3.96B, and gross margin of 60.5%-62.5%. It's forecasting operating expenses of $785M, interest and other expenses of $101M and has a $73M provision for income taxes.</li>     <li>\n<a href=\"http://investors.broadcom.com/phoenix.zhtml?c=203541&amp;p=irol-EventDetails&amp;EventId=5242303\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3229550\" data-linked=\"Broadcom +2.6% as earnings report features beat, doubled dividend\" data-tweet=\"$AVGO - Broadcom +2.6% as earnings report features beat, doubled dividend https://seekingalpha.com/news/3229550-broadcomplus-2_6-earnings-report-features-beat-doubled-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3229550-broadcomplus-2_6-earnings-report-features-beat-doubled-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229515\" data-ts=\"1481231952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229515-finisar-active-on-strong-q2-outlook-currentlyplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar active on strong Q2, outlook; currently +2%</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3229519-finisar-beats-0_12-beats-revenue\" target=\"_blank\">Results</a></strong> \u2013 revenue $369.86M (+15.2% Y/Y, <font color=\"green\">$7.8M above estimates</font>), EPS $0.58 (<font color=\"green\">$0.12 above estimates</font>), gross margin 37.2% (vs. 33.1% Q/Q), operating expenses $69.4M (vs. $69.3M Q/Q), operating margin 18.5% (vs. 12.8% Q/Q), cash, cash equivalents and short-term investments $626.3M (+$32.5M Q/Q)</li>\n<li>\n<strong>Q3 projections</strong> \u2013 revenue $378M-$398M (<a href=\"https://finance.yahoo.com/quote/FNSR/analysts?p=FNSR\" target=\"_blank\">consensus $376.56M</a>), gross margin 37%-38%, operating margin 18.5%-19.5%, EPS $0.58-$0.64 (consensus $0.48)</li>\n<li>Finisar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a>) CEO Jerry Rawls: \"This growth was primarily driven by strong demand for 100G transceivers. In addition, customer demand for wavelength selective switch and ROADM line card products was strong. Our gross margins improved significantly due to a favorable product mix and leverage achieved from our vertical integration with larger volumes. The combination of revenues being at the higher end of our guidance range with higher gross margins resulted in earnings per fully diluted share above our guidance range.\"</li>\n<li><a href=\"http://edge.media-server.com/m/p/69wub2mh\" target=\"_blank\">Conference call</a></li>\n<li><a href=\"http://files.shareholder.com/downloads/FNSR/3392009363x0x920565/0FE348B6-0BD3-4866-98B8-EBAA2C409E99/Q2FY17_Earnings_Call_Slides_--_12-8-16.pdf\" target=\"_blank\">Presentation</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229515\" data-linked=\"Finisar active on strong Q2, outlook; currently +2%\" data-tweet=\"$FNSR - Finisar active on strong Q2, outlook; currently +2% https://seekingalpha.com/news/3229515-finisar-active-on-strong-q2-outlook-currentlyplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3229515-finisar-active-on-strong-q2-outlook-currentlyplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229543\" data-ts=\"1481231799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229543-restoration-hardware-crushed-after-holiday-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restoration Hardware crushed after holiday guidance disappoints</a></h4><ul>     <li>Restoration Hardware (NYSE:<a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a>) lowers full-year profit guidance after citing weak holiday sales.</li>        <li>\"Our business in November was below our expectations, which we largely attribute to consumer softness related to the US election and our Fall 2016 Source Books getting in homes later than planned,\" notes CEO Gary Friedman.</li> <li>The company now sees FY16 EPS falling in a range of $1.19-$1.29 vs. $1.60-$1.80 prior and $1.63 consensus.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3229527-restoration-hardware-beats-0_04-beats-revenue\" target=\"_blank\">Restoration Hardware beats by $0.04, beats on revenue</a> (Dec. 8)</li>\n<li>RH <font color=\"red\">-18.80%</font> AH to $31.83.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229543\" data-linked=\"Restoration Hardware crushed after holiday guidance disappoints\" data-tweet=\"$RH - Restoration Hardware crushed after holiday guidance disappoints https://seekingalpha.com/news/3229543-restoration-hardware-crushed-after-holiday-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3229543-restoration-hardware-crushed-after-holiday-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229536\" data-ts=\"1481231507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229536-broadcom-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom beats by $0.09, beats on revenue</a></h4><ul>\n<li>Broadcom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a>): FQ4 EPS of $3.47 <font color=\"green\">beats by $0.09</font>.</li>\n<li>Revenue of $4.13B (+123.9% Y/Y) <font color=\"green\">beats by $20M</font>.</li>\n<li>Shares <font color=\"green\">+2.5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229536\" data-linked=\"Broadcom beats by $0.09, beats on revenue\" data-tweet=\"$AVGO - Broadcom beats by $0.09, beats on revenue https://seekingalpha.com/news/3229536-broadcom-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3229536-broadcom-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229519\" data-ts=\"1481230910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229519-finisar-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar beats by $0.12, beats on revenue</a></h4><ul>\n<li>Finisar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a>): FQ2 EPS of $0.58 <font color=\"green\">beats by $0.12</font>.</li>\n<li>Revenue of $369.86M (+15.2% Y/Y) <font color=\"green\">beats by $7.87M</font>.</li>\n<li>Shares <font color=\"green\">+6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229519\" data-linked=\"Finisar beats by $0.12, beats on revenue\" data-tweet=\"$FNSR - Finisar beats by $0.12, beats on revenue https://seekingalpha.com/news/3229519-finisar-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3229519-finisar-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229513\" data-ts=\"1481229898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229513-tyson-foodsplus-4-after-conference-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods +4% after conference presentation</a></h4><ul>     <li>Tyson Foods (NYSE:<a href=\"https://seekingalpha.com/symbol/TSN\" title=\"Tyson Foods Inc.\">TSN</a>) is <font color=\"green\">up 4.35%</font> as investors continue to snap up shares following yesterday's presentation at the Bernstein Consumer Summit.</li>     <li>CFO Dennis Leatherby drew attention when he said the company is positioned to make another Hillshire-sized acquisition.</li>     <li>A confident tone was also struck by Tyson management over the price collusion allegations.</li>     <li>Tysons says it's having a a good beginning to the fiscal year. \"The first quarter is off to a phenomenal start,\" noted CEO Tom Hayes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229513\" data-linked=\"Tyson Foods +4% after conference presentation\" data-tweet=\"$TSN - Tyson Foods +4% after conference presentation https://seekingalpha.com/news/3229513-tyson-foodsplus-4-after-conference-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3229513-tyson-foodsplus-4-after-conference-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229511\" data-ts=\"1481229672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229511-biogen-perks-up-on-leaked-trial-data-on-alzheimers-candidate-aducanumab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen perks up on leaked trial data on Alzheimer&#39;s candidate aducanumab</a></h4><ul>\n<li>Biogen (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+1.2%</font>) is in positive territory for the day after <a href=\"https://www.thestreet.com/story/13919848/1/biogen-shares-spike-higher-on-leaked-alzheimer-s-drug-data.html\" target=\"_blank\">data were leaked</a> from a Phase 1 clinical trial, PRIME, investigating Alzheimer's disease (AD) candidate aducanumab. The results will be presented in a research meeting tomorrow.</li>\n<li>Titration dosing of aducanumb up to 10 mg/kg produced significant reductions in amyloid plaque burden during the 12 months of treatment. The slowing of cognitive and functional decline as measured by a scale called CDR-SB in aducanumab-treated patients was statistically significant compared to placebo.</li>\n<li>Data from the long-term phase showed patients receiving aducanumab continued to show a decrease in brain amyloid plaque burden in a dose- and time-dependent manner over 24 months (measured by PET scan).</li>\n<li>\n<a href=\"http://www.neurimmune.com/products/alzheimers-disease.html\" target=\"_blank\">Aducanumab </a>is a human recombinant monoclonal antibody derived from a library of B cells collected from healthy elderly subjects with no signs of cognitive impairment. It is being developed under a <a href=\"http://www.neurimmune.com/newsartikel/20112007-biogen-idec-and-neurimmune-therapeutics-announce-alliance-to-develop-treatments-for-alzheimers-disease-.html\" target=\"_blank\">global deal</a> with <a href=\"http://www.neurimmune.com/company/about-neurimmune.html\" target=\"_blank\">Neurimmune</a> inked in November 2007.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229511\" data-linked=\"Biogen perks up on leaked trial data on Alzheimer&#39;s candidate aducanumab\" data-tweet=\"$BIIB - Biogen perks up on leaked trial data on Alzheimer&#39;s candidate aducanumab https://seekingalpha.com/news/3229511-biogen-perks-up-on-leaked-trial-data-on-alzheimers-candidate-aducanumab?source=tweet\" data-url=\"https://seekingalpha.com/news/3229511-biogen-perks-up-on-leaked-trial-data-on-alzheimers-candidate-aducanumab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229512\" data-ts=\"1481229482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLR\" target=\"_blank\">CLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229512-continental-resources-cut-to-hold-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Continental Resources cut to Hold at Deutsche Bank</a></h4><ul>\n<li>Continental Resources (<a href=\"https://seekingalpha.com/symbol/CLR\" title=\"Continental Resources, Inc.\">CLR</a> <font color=\"red\">-1.6%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Downgrades+Continental+Resources+%28CLR%29+to+Hold/12323753.html\" target=\"_blank\">downgraded</a> to Hold from Buy with a $64 price target at Deutsche Bank as the company continues to shift exposure to Permian Basin.</li>\n<li>Although more STACK  well results are still ahead, the firm thinks 2016 likely was more rich in catalysts for CLR, and while visibility in the  forward outlook has significantly improved post OPEC, it sees the shares largely reflecting this view.</li>\n<li>Deutsche Bank says investors  should have some exposure outside the Permian and sees better value  in other diversified producers with similar or better balance sheet  profiles, including Newfield Exploration (<a href=\"https://seekingalpha.com/symbol/NFX\" title=\"Newfield Exploration Co.\">NFX</a> <font color=\"green\">+1.4%</font>), Oasis Petroleum (<a href=\"https://seekingalpha.com/symbol/OAS\" title=\"Oasis Petroleum Inc.\">OAS</a> <font color=\"green\">+0.9%</font>), QEP Resources (<a href=\"https://seekingalpha.com/symbol/QEP\" title=\"QEP Resources, Inc.\">QEP</a> <font color=\"green\">+0.8%</font>), Encana (<a href=\"https://seekingalpha.com/symbol/ECA\" title=\"Encana Corporation\">ECA</a> <font color=\"green\">+3.3%</font>) and WPX Energy (<a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a> <font color=\"red\">-0.3%</font>).</li>\n<li>CLR also has been downgraded at J.P. Morgan and KLR Group in recent days.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229512\" data-linked=\"Continental Resources cut to Hold at Deutsche Bank\" data-tweet=\"$CLR $CLR $NFX - Continental Resources cut to Hold at Deutsche Bank https://seekingalpha.com/news/3229512-continental-resources-cut-to-hold-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3229512-continental-resources-cut-to-hold-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229509\" data-ts=\"1481228343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZZ\" target=\"_blank\">AZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229509-azz-cut-to-sell-stifel-q3-fall-short-of-investor-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AZZ cut to Sell at Stifel, as Q3 could fall short of investor expectations</a></h4><ul>     <li>AZZ (<a href=\"https://seekingalpha.com/symbol/AZZ\" title=\"AZZ incorporated\">AZZ</a> <font color=\"red\">-7.2%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Stifel+Downgrades+AZZ+Inc.+%28AZZ%29+to+Sell/12323688.html\" target=\"_blank\">downgraded to Sell</a> from Hold with a $57 price target, cut from $63, at Stifel, which believes shares are extended ahead of Q3 results that could miss investor expectations.</li>\n<li>Stifel also thinks a continuation of AZZ's FQ2 volume challenges into Q3 will reign in investor ebullience and bring focus back to the  next 12-month outlook, driving multiple compression; combined  with what it anticipates will be downward revisions to earnings, the firm  sees meaningful downside to shares at current levels.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229509\" data-linked=\"AZZ cut to Sell at Stifel, as Q3 could fall short of investor expectations\" data-tweet=\"$AZZ - AZZ cut to Sell at Stifel, as Q3 could fall short of investor expectations https://seekingalpha.com/news/3229509-azz-cut-to-sell-stifel-q3-fall-short-of-investor-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3229509-azz-cut-to-sell-stifel-q3-fall-short-of-investor-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229507\" data-ts=\"1481228032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229507-timeplus-7-hiring-bankers-to-discuss-buyout-offers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time +7%; hiring bankers to discuss buyout offers</a></h4><ul>    <li>Time Inc. (TIME) has <font color=\"green\">jumped 7%</font> on word that it's <a href=\"http://www.wsj.com/articles/time-inc-hires-banks-to-help-field-takeover-partnership-interest-1481227801\" target=\"_blank\">fielding takeover offers</a> and has hired bankers for that purpose, after news that it's getting overtures from a group led by Edgar Bronfman Jr.</li>    <li>The company's engaged with Morgan Stanley and Bank of America to discuss offers, <i>The Wall Street Journal</i> reports.</li>\n<li>Bronfman runs a private-equity firm now but is the former CEO of Warner Music Group. He's reportedly partnering with Ynon Kreiz and Len Blavatnik on an $18/share offer, so far rebuffed by Time, which closed yesterday at $16.45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229507\" data-linked=\"Time +7%; hiring bankers to discuss buyout offers\" data-tweet=\"$MDP - Time +7%; hiring bankers to discuss buyout offers https://seekingalpha.com/news/3229507-timeplus-7-hiring-bankers-to-discuss-buyout-offers?source=tweet\" data-url=\"https://seekingalpha.com/news/3229507-timeplus-7-hiring-bankers-to-discuss-buyout-offers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229504\" data-ts=\"1481227283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229504-macau-stocks-stung-beijing-crackdown-on-atm-withdrawals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau stocks stung by Beijing crackdown on ATM withdrawals</a></h4><ul>     <li>Macau stocks are down sharply after South China Morning Post <a href=\"http://www.scmp.com/news/hong-kong/economy/article/2053045/beijing-takes-aim-macau-gaming-industry-cut-currency-flight\" target=\"_blank\">reports</a> that Beijing is taking aim at the flight of capital from Macau.</li><li>The Monetary Authority of Macau is poised to limit the amount of cash China UnionPay bank cardholders can withdraw per day from ATM machines to 5K patacas from 10K.</li><li>The policy is expected to take effect this weekend.</li><li>Movers: Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='red'>-9.9%</font>), Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color='red'>-11.6%</font>), Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a> <font color='red'>-2.9%</font>), Melco Crown (MPEL <font color='red'>-12.2%</font>) and MGM Resorts (<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a> <font color='red'>-4.3%</font>)</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3229504\" data-linked=\"Macau stocks stung by Beijing crackdown on ATM withdrawals\" data-tweet=\"$WYNN $WYNN $LVS - Macau stocks stung by Beijing crackdown on ATM withdrawals https://seekingalpha.com/news/3229504-macau-stocks-stung-beijing-crackdown-on-atm-withdrawals?source=tweet\" data-url=\"https://seekingalpha.com/news/3229504-macau-stocks-stung-beijing-crackdown-on-atm-withdrawals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229503\" data-ts=\"1481227269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229503-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> COOL <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AIRG' title='Airgain'>AIRG</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229503\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$PTE $FNCX $CIEN - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3229503-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229503-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229495\" data-ts=\"1481224896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229495-sunpower-restructuring-bad-sign-for-pv-industry-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunPower restructuring a bad sign for PV industry, analyst says</a></h4><ul>     <li>SunPower's (<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"red\">-4.7%</font>) <a href=\"https://seekingalpha.com/news/3229089-sunpower-announces-restructuring-program-including-2500-job-cuts\" target=\"_blank\">new restructuring plan</a> is indicative of worsening solar photovoltaic market fundamentals, Axiom\u2019s Gordon Johnson says.</li>     <li>The analyst says SPWR thinks the U.S. residential market has \u201ccorrected\u201d while he believes the correction seems \u201cfar from over,\" manufacturers continue to expand capacity causing price competition that is driving ASPs to new lows, lower cost targets translate to lower growth given the capital intensity of SPWR's PV projects.</li>     <li>Johnson has Sell ratings on SunEdison (<a href=\"https://seekingalpha.com/symbol/SUNEQ\" title=\"SunEdison, Inc.\">OTCPK:SUNEQ</a> <font color=\"red\">-5.8%</font>), JA Solar (<a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-4%</font>), Trina Solar (<a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a>), Yingli Green Energy (<a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"red\">-3.1%</font>) and SolarEdge (<a href=\"https://seekingalpha.com/symbol/SEDG\" title=\"SolarEdge Technologies\">SEDG</a> <font color=\"red\">-2.1%</font>).</li>     <li>Morgan Stanley says it <a href=\"http://247wallst.com/energy-business/2016/12/08/morgan-stanley-cautious-on-solar-industry-sunpower/\" target=\"_blank\">remains cautious</a> on the 2017 outlook given limited indications of a PV industry recovery, also noting that SPWR did not provide margin or EBITDA targets and said it would focus on maximizing cash flow and liquidity rather than to growth; the firm rates SPWR at Equal Weight with a $6 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229495\" data-linked=\"SunPower restructuring a bad sign for PV industry, analyst says\" data-tweet=\"$SPWR $SPWR $SUNEQ - SunPower restructuring a bad sign for PV industry, analyst says https://seekingalpha.com/news/3229495-sunpower-restructuring-bad-sign-for-pv-industry-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3229495-sunpower-restructuring-bad-sign-for-pv-industry-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229491\" data-ts=\"1481223931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229491-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SXCL' title='Steel Excel Inc.'>SXCL</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CVI' title='CVR Energy, Inc.'>CVI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+15%</font>. TVIA <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/TTI' title='Tetra Technologies Inc.'>TTI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229491\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$SXCL $NAK $CVI - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3229491-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229491-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229487\" data-ts=\"1481222693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEG\" target=\"_blank\">MEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229487-media-general-extends-lin-television-note-purchase-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Media General extends LIN Television note purchase offer</a></h4><ul>     <li>Media General (NYSE:<a href=\"https://seekingalpha.com/symbol/MEG\" title=\"Media General\">MEG</a>), <font color=\"green\">up 1.7%</font> to a two-year high, has extended a change of control offer to purchase notes issued by its LIN Television unit.</li>     <li>The offer to pay cash (at 101% of principal) for outstanding 5.875% senior notes due 2022 was set to expire at midnight last night, but has been extended a week.</li>     <li>The company had received tenders from holders of $28.75M in principal (about 7.19% of outstanding principal) by 5 p.m. ET yesterday.</li>     <li>The move comes in conjunction with the company's plans to merge with Nexstar Broadcasting Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NXST\" title=\"Nexstar Media Group, Inc.\">NXST</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229487\" data-linked=\"Media General extends LIN Television note purchase offer\" data-tweet=\"$MEG $MEG $NXST - Media General extends LIN Television note purchase offer https://seekingalpha.com/news/3229487-media-general-extends-lin-television-note-purchase-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3229487-media-general-extends-lin-television-note-purchase-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229486\" data-ts=\"1481222604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGNX\" target=\"_blank\">CGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229486-deutsche-bank-initiates-cognex-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank initiates Cognex at Buy</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Starts+Cognex+%28CGNX%29+at+Buy/12323811.html\" target=\"_blank\">With a $74 target</a> (current price $63.37).</li>\n<li>Analyst Karen Lau attributes healthy growth rates within the machine vision industry (high single to low double-digit annuals), Cognex product sales for factory automation implementations that are above that pace, prospects within logistics ID and mobile computing, a projected rise in automation investment on possible trade policy revisions and other catalysts.</li>\n<li>Cognex (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CGNX\" title=\"Cognex Corporation\">CGNX</a>) shares have been on a steady trajectory of late, <font color=\"green\">higher by 7%</font> today, <font color=\"green\">16%</font> on the month, <font color=\"green\">28%</font> over the last three and <font color=\"green\">73%</font> since this point last December.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229486\" data-linked=\"Deutsche Bank initiates Cognex at Buy\" data-tweet=\"$CGNX - Deutsche Bank initiates Cognex at Buy https://seekingalpha.com/news/3229486-deutsche-bank-initiates-cognex-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3229486-deutsche-bank-initiates-cognex-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229485\" data-ts=\"1481221986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYD\" target=\"_blank\">BYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229485-deutsche-bank-lifts-estimates-on-regional-casino-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank lifts estimates on regional casino stocks</a></h4><ul>     <li>Boyd Gaming (<a href=\"https://seekingalpha.com/symbol/BYD\" title=\"Boyd Gaming Corporation\">BYD</a> <font color=\"green\">+5%</font>) rallies after Deutsche Bank names the stock its top regional gaming pick.</li>     <li>Analyst Carlo Santarelli thinks macro factors are setting up favorably for the broad regional casino sector to set it up for margin expansion.</li>\n<li>Price target hikes:  Penn National Gaming (<a href=\"https://seekingalpha.com/symbol/PENN\" title=\"Penn National Gaming, Inc.\">PENN</a> <font color=\"green\">+3.3%</font>) to $18 from $17, Pinnacle Entertainment (<a href=\"https://seekingalpha.com/symbol/PNK\" title=\"Pinnacle Entertainment, Inc.\">PNK</a> <font color=\"green\">+0.9%</font>) to $16 from $13 and Red Rock Resorts (<a href=\"https://seekingalpha.com/symbol/RRR\" title=\"Red Rock Resorts\">RRR</a> <font color=\"green\">+0.8%</font>) to $28 from $26.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3229485\" data-linked=\"Deutsche Bank lifts estimates on regional casino stocks\" data-tweet=\"$BYD $BYD $PENN - Deutsche Bank lifts estimates on regional casino stocks https://seekingalpha.com/news/3229485-deutsche-bank-lifts-estimates-on-regional-casino-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3229485-deutsche-bank-lifts-estimates-on-regional-casino-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229476\" data-ts=\"1481220258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDUS\" target=\"_blank\">RDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229476-radius-health-fails-to-impress-early-stage-rad1901-data-shares-slump-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radius Health fails to impress with early-stage RAD1901 data; shares slump 18%</a></h4><ul>\n<li>Radius Health (<a href=\"https://seekingalpha.com/symbol/RDUS\" title=\"Radius Health, Inc.\">RDUS</a> <font color=\"red\">-17.7%</font>) is getting some rude treatment today on more than double normal volume. Investors were apparently expecting good news when the company announced data from two Phase 1 trials on breast cancer candidate RAD1901 in San Antonio earlier today but instead got a some rather tepid numbers.</li>\n<li>As of the October 7 cut-off date in the first study, 20 heavily pretreated patients with ER+, HER2- advanced breast cancer had been treated in the Phase 1b safety expansion cohort at the 400 mg dose. 95% (n=19/20) had measurable disease at baseline. There were only two partial responders. Across the dose escalation phase (n=13) and safety expansion cohort (n=20), 14 patients were on study drug for at least four months, five patients were on at least six months and seven remained on treatment.</li>\n<li>In its ongoing Phase 1 study in Europe, three patients were enrolled at the 400 mg dose as of October 7. Only one had a confirmed partial response. All patients remained on treatment for a mean duration of 5.64 cycles.</li>\n<li>RAD1901 is a selective estrogen receptor degrader. It is also being investigated for the treatment of hot flashes in postmenopausal women.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229476\" data-linked=\"Radius Health fails to impress with early-stage RAD1901 data; shares slump 18%\" data-tweet=\"$RDUS - Radius Health fails to impress with early-stage RAD1901 data; shares slump 18% https://seekingalpha.com/news/3229476-radius-health-fails-to-impress-early-stage-rad1901-data-shares-slump-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3229476-radius-health-fails-to-impress-early-stage-rad1901-data-shares-slump-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229479\" data-ts=\"1481220022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229479-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> WAC <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CDOR' title='Condor Hospitality Trust, Inc.'>CDOR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FRBA' title='First Bank &#40;Nj&#41;'>FRBA</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a> <font color='green'>+7%</font>. FXCM <font color='green'>+7%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LPLA' title='LPL Financial Holdings Inc.'>LPLA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229479\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$DHCP $CDOR $FRBA - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3229479-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229479-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229473\" data-ts=\"1481218966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229473-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/UTI' title='Universal Technical Institute'>UTI</a> <font color='green'>+46%</font>. COOL <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/SXCL' title='Steel Excel Inc.'>SXCL</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='green'>+27%</font>. WAC <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/AIRI' title='Air Industries Group, Inc.'>AIRI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='red'>-44%</font>. <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc'>AJRD</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229473\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$UTI $PTE $TLRD - Midday Gainers / Losers https://seekingalpha.com/news/3229473-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3229473-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229471\" data-ts=\"1481218954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OREX\" target=\"_blank\">OREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229471-orexigen-establishes-mysimba-distribution-in-uk-and-ireland-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orexigen establishes Mysimba distribution in the UK and Ireland; shares up 6%</a></h4><ul>\n<li>Thinly traded nano cap Orexigen Therapeutics (<a href=\"https://seekingalpha.com/symbol/OREX\" title=\"Orexigen Therapeutics, Inc.\">OREX</a> <font color=\"green\">+6%</font>) perks up on almost triple normal volume, albeit on turnover of only 287K shares, in apparent response to its announcement that its subsidiary has inked a deal with Consilient Health Ltd. for the commercialization and distribution of obesity med Mysimba (naltrexone HCl/bupropion HCl prolonged release) in the UK and Ireland.</li>\n<li>The European Commission approved Mysimba in March 2015.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229471\" data-linked=\"Orexigen establishes Mysimba distribution in the UK and Ireland; shares up 6%\" data-tweet=\"$OREX - Orexigen establishes Mysimba distribution in the UK and Ireland; shares up 6% https://seekingalpha.com/news/3229471-orexigen-establishes-mysimba-distribution-in-uk-and-ireland-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3229471-orexigen-establishes-mysimba-distribution-in-uk-and-ireland-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229470\" data-ts=\"1481218365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHMD\" target=\"_blank\">PHMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229470-photomedex-still-on-tear-shares-up-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PhotoMedex still on a tear; shares up 23%</a></h4><ul><li>Thinly traded nano cap PhotoMedex (<a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='green'>+23%</font>) is the latest siren song for naive investors looking for a quick buck. Shares have ballooned almost five-fold since early November. No particular news accounts for the action which could mean that an equity offering is on the way.</li><li>In June, DS Healthcare (<a href='https://seekingalpha.com/symbol/DSKX' title='DS Healthcare Group, Inc.'>OTC:DSKX</a>)&nbsp;announced that it would acquire the company for $48M but the deal fell apart.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229470\" data-linked=\"PhotoMedex still on a tear; shares up 23%\" data-tweet=\"$PHMD $PHMD $DSKX - PhotoMedex still on a tear; shares up 23% https://seekingalpha.com/news/3229470-photomedex-still-on-tear-shares-up-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3229470-photomedex-still-on-tear-shares-up-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229454\" data-ts=\"1481216359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229454-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>    <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+16%</font>. LTEA <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ABAC-OLD' title='Renmin Tianli Group'>ABAC-OLD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229454\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LULU $LBCC $ABAC-OLD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3229454-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3229454-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229453\" data-ts=\"1481216221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229453-soligenixs-dusquetide-shows-long-term-safety-in-follow-up-to-mid-stage-study-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix&#39;s dusquetide shows long-term safety in follow-up to mid-stage study; shares up 6%</a></h4><ul>\n<li>Long-term follow-up data from a Phase 2 study assessing Soligenix's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SNGX\" title=\"Soligenix, Inc.\">SNGX</a>) dusquetide (SGX942) for the treatment of oral mucositis (OM) head and neck cancer patients undergoing chemoradiation therapy (CRT) showed dusquetide to be safe and well-tolerated. The observations in the 12-month period were consistent with those made in the four-week acute phase of the trial. In addition, dusquetide did not interfere with CRT as evidenced by improved survival and tumor resolution over the period. No drug-toxicities were reported.</li>\n<li>Results first <a href=\"http://www.soligenix.com/news/soligenix-announces-positive-preliminary-results-from-its-phase-2-clinical-trial-of-sgx942-for-the-treatment-of-oral-mucositis-in-head-and-neck-cancer-patients/\" target=\"_blank\">announced </a>in December 2015 showed treatment with dusquetide reduced the median duration of severe OM by 50% in all patients compared to placebo. In those at high risk of developing severe OM, the median reduction was 67%.</li>\n<li>A pivotal Phase 2b/3 is the next step.</li>\n<li>\n<a href=\"http://www.soligenix.com/pipeline/vaccinesbiodefense/sgx943-melioidosis/\" target=\"_blank\">Dusquetide </a>is a member of a class of peptides called an innate defense regulator (IDR) which has no direct antibiotic activity but modulates host responses, increasing survival and accelerating the resolution of tissue damage following exposure to pathogens.</li>\n<li>OM usually occurs in the mouth of patents undergoing anticancer treatments. Almost all head and neck cancer patients receiving chemo develop OM.</li>\n<li>The company will host an investor webcast on December 16 at 8:30 am ET to discuss the clinical environment related to OM, IDRs and the study data.</li>\n<li>Shares are up <font color=\"green\">6%</font> on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229453\" data-linked=\"Soligenix&#39;s dusquetide shows long-term safety in follow-up to mid-stage study; shares up 6%\" data-tweet=\"$SNGX - Soligenix&#39;s dusquetide shows long-term safety in follow-up to mid-stage study; shares up 6% https://seekingalpha.com/news/3229453-soligenixs-dusquetide-shows-long-term-safety-in-follow-up-to-mid-stage-study-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3229453-soligenixs-dusquetide-shows-long-term-safety-in-follow-up-to-mid-stage-study-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229449\" data-ts=\"1481215307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229449-u-s-steel-says-ceo-meant-restoring-10k-jobs-in-overall-steel-industry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel says CEO meant restoring 10K jobs in overall steel industry</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-2%</font>) clarifies comments made yesterday by CEO Mario Longhi, saying he was referring to the overall U.S. steel industry, not just the company, when he spoke about potentially <a href=\"https://seekingalpha.com/news/3229261-u-s-steel-restore-10k-u-s-jobs-ceo-longhi-tells-cnbc\" target=\"_blank\">restoring up to 10K jobs</a>  in the U.S.</li>\n<li>Responding to a question in a CNBC interview about initiatives proposed by Pres.-elect Trump, Longhi said, \"I'm more than happy to bring back the employees that we were  forced to lay off during the depressing period... [which] could be  close to 10,000 jobs.\"</li>\n<li>The domestic steel industry has been forced to lay off 16K-plus employees since January 2015; U.S. Steel has cut ~7K jobs since 2007.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229449\" data-linked=\"U.S. Steel says CEO meant restoring 10K jobs in overall steel industry\" data-tweet=\"$X - U.S. Steel says CEO meant restoring 10K jobs in overall steel industry https://seekingalpha.com/news/3229449-u-s-steel-says-ceo-meant-restoring-10k-jobs-in-overall-steel-industry?source=tweet\" data-url=\"https://seekingalpha.com/news/3229449-u-s-steel-says-ceo-meant-restoring-10k-jobs-in-overall-steel-industry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229448\" data-ts=\"1481215187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229448-alibaba-set-130-target-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba set with $130 target at Morgan Stanley</a></h4><ul>\n<li>Morgan Stanley analyst Grace Chen <a href=\"http://www.cnbc.com/2016/12/08/alibaba-to-rally-40-percent-plus-on-its-emerging-cloud-computing-business-morgan-stanley-says.html\" target=\"_blank\">assumes Overweight coverage</a> of Alibaba (<a href=\"https://seekingalpha.com/symbol/BABA\" title=\"Alibaba Group Holding Limited\">BABA</a> <font color=\"green\">+1.5%</font>), citing underappreciated efforts to upgrade the company's e-commerce business, its main profit driver, and potential for strategic initiatives beyond e-commerce, particularly AliCloud.</li>\n<li>She's <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2016/12/08/alibaba-has-40-upside-morgan-stanley-says/\" target=\"_blank\">modeling</a> AliCloud sales of $1B at near breakeven for FY 2017 and to $3B in FY 2019. Comparatively, Amazon drew <a href=\"https://seekingalpha.com/news/3217726-amazon-minus-6-percent-major-q3-eps-shortfall-updated\" target=\"_blank\">$3.231B</a> from its AWS segment in the most recently reported quarter alone.</li>\n<li>Alibaba's (NYSE:<a href=\"https://seekingalpha.com/symbol/BABA\" title=\"Alibaba Group Holding Limited\">BABA</a>) to $92.42 at midday, <font color=\"green\">roughly 1.5%</font> higher on the session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229448\" data-linked=\"Alibaba set with $130 target at Morgan Stanley\" data-tweet=\"$BABA - Alibaba set with $130 target at Morgan Stanley https://seekingalpha.com/news/3229448-alibaba-set-130-target-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3229448-alibaba-set-130-target-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229442\" data-ts=\"1481213412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229442-bank-of-america-rally-takes-to-2008-level\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of America rally takes it to 2008 level</a></h4><ul> <li>Shares of Bank of America (NYSE:<a href=\"https://seekingalpha.com/symbol/BAC\" title=\"Bank of America Corporation\">BAC</a>) are at an 8-year high after <font color=\"green\">adding on another 1.15%</font> today.</li> <li>While the bull case on BofA's common stock is tied to a positive mix of higher interest rates and lower expenses, SA contributor Arbitrage Trader says investors have an <a href=\"https://seekingalpha.com/article/4029137-bank-america-preferred-stocks-mispriced\" target=\"_blank\">arbitrage opportunity</a> with the BAC floating rate preferred shares. The trade can't be scaled up, but could be intriguing for an individual investor.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3229442\" data-linked=\"Bank of America rally takes it to 2008 level\" data-tweet=\"$BAC - Bank of America rally takes it to 2008 level https://seekingalpha.com/news/3229442-bank-of-america-rally-takes-to-2008-level?source=tweet\" data-url=\"https://seekingalpha.com/news/3229442-bank-of-america-rally-takes-to-2008-level\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229424\" data-ts=\"1481212802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229424-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay'>VRAY</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229424\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$PHMD $VYGR $TROV - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3229424-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3229424-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229438\" data-ts=\"1481212466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229438-majesco-entertainment-and-polarityte-to-merge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Majesco Entertainment and PolarityTE to merge</a></h4><ul> <li>Majesco Entertainment (COOL) is <font color=\"green\">up 47%</font> to $4.66 after the company announces that it's merging with PolarityTE.</li> <li>Polarity will become a wholly-owned subsidiary of Majesco.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3229438\" data-linked=\"Majesco Entertainment and PolarityTE to merge\" data-tweet=\"$PTE - Majesco Entertainment and PolarityTE to merge https://seekingalpha.com/news/3229438-majesco-entertainment-and-polarityte-to-merge?source=tweet\" data-url=\"https://seekingalpha.com/news/3229438-majesco-entertainment-and-polarityte-to-merge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229437\" data-ts=\"1481212289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTI\" target=\"_blank\">TTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229437-tetra-techminus-15-eyes-capital-raise-alternatives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TETRA Tech -15% as it eyes capital raise alternatives</a></h4><ul>     <li>TETRA Tech (<a href=\"https://seekingalpha.com/symbol/TTI\" title=\"Tetra Technologies Inc.\">TTI</a> <font color=\"red\">-15%</font>) says it is considering capital raise alternatives to address potential weakness in 2017 deepwater Gulf of Mexico activity and the  deferral of certain projects from Q4 into early 2017.</li>     <li>TTI says the delay in these projects is expected to result in non-compliance with one of its debt covenants as of Dec. 31.</li>     <li>TTI says it intends to pursue opportunities to raise the capital necessary to strengthen its balance sheet in what it believes to be a recovering market.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229437\" data-linked=\"TETRA Tech -15% as it eyes capital raise alternatives\" data-tweet=\"$TTI - TETRA Tech -15% as it eyes capital raise alternatives https://seekingalpha.com/news/3229437-tetra-techminus-15-eyes-capital-raise-alternatives?source=tweet\" data-url=\"https://seekingalpha.com/news/3229437-tetra-techminus-15-eyes-capital-raise-alternatives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229431\" data-ts=\"1481211014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229431-eia-natural-gas-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Natural gas inventory</a></h4><ul>     <li>\n<a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>-42</strong><strong> Bcf</strong> vs. -43 Bcf consensus -50 Bcf last week.</li>     <li>Futures <font color=\"green\">+1.05%</font> to $3.641.</li>     <li>ETFs: <a href=\"https://seekingalpha.com/symbol/UNG\" title=\"The United States Natural Gas ETF, LP\">UNG</a>, <a href=\"https://seekingalpha.com/symbol/DGAZ\" title=\"VelocityShares 3x Inverse Natural Gas ETN\">DGAZ</a>, <a href=\"https://seekingalpha.com/symbol/UGAZ\" title=\"VelocityShares 3x Long Natural Gas ETN\">UGAZ</a>, <a href=\"https://seekingalpha.com/symbol/BOIL\" title=\"ProShares Ultra Bloomberg Natural Gas ETF\">BOIL</a>, <a href=\"https://seekingalpha.com/symbol/GAZ\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ</a>, <a href=\"https://seekingalpha.com/symbol/KOLD\" title=\"ProShares UltraShort Bloomberg Natural Gas ETF\">KOLD</a>, <a href=\"https://seekingalpha.com/symbol/UNL\" title=\"The United States 12 Month Natural Gas ETF, LP\">UNL</a>, <a href=\"https://seekingalpha.com/symbol/DCNG\" title=\"iPath Pure Beta Seasonal Natural Gas ETN\">DCNG</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229431\" data-linked=\"EIA Natural gas inventory\" data-tweet=\"$UNG $DGAZ $UGAZ - EIA Natural gas inventory https://seekingalpha.com/news/3229431-eia-natural-gas-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3229431-eia-natural-gas-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229430\" data-ts=\"1481210886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIAV\" target=\"_blank\">VIAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229430-viavi-solutions-upgraded-to-buy-craig-hallum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viavi Solutions upgraded to Buy at Craig-Hallum</a></h4><ul>\n<li>\n<a href=\"http://blogs.barrons.com/techtraderdaily/2016/12/08/tech-today-ciena-amd-juniper-all-surge-viavi-and-apple/?mod=BOLBlog\" target=\"_blank\">Analyst Richard Shannon</a> moves from Hold prior, particularly citing the company's strength in optical coating technology and possibility Apple is the source of a large prepayment recently recorded.</li>\n<li>Shares in Viavi Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VIAV\" title=\"Viavi Solutions Inc.\">VIAV</a>) are <font color=\"green\">higher by 1.32%</font> early, overall <font color=\"green\">up 11%+ </font>since last week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229430\" data-linked=\"Viavi Solutions upgraded to Buy at Craig-Hallum\" data-tweet=\"$VIAV - Viavi Solutions upgraded to Buy at Craig-Hallum https://seekingalpha.com/news/3229430-viavi-solutions-upgraded-to-buy-craig-hallum?source=tweet\" data-url=\"https://seekingalpha.com/news/3229430-viavi-solutions-upgraded-to-buy-craig-hallum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229428\" data-ts=\"1481210607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229428-lululemon-skyrockets-investors-bet-on-bright-future\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon skyrockets as investors bet on bright future</a></h4><ul>     <li>Lululemon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a>) is back over $70 for the first time since early September as investors take heart after CEO Laurent Potdevin says the company is on track to hit $4B in revenue by 2021.</li>     <li>The retailer's sales were impressive during the key shopping days of Black Friday (+16%) and Cyber Monday (+29%) on what management says was a strong mix of full price selling.</li>   <li>Sports bras sales rose more than 20% during the quarter, according to Potdevin. He also noted that LULU has \"fantastic innovation\" regarding its bras on the way next year.</li>     <li>\"We are impressed with the company\u2019s ability to deliver both positive store comps and 16% eCommerce growth despite industry average traffic decline (in the mid-single digits),\" observes Mizuho analyst Betty Chen.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3229237-lululemon-plus-11_5-percent-beat-buyback-guidance-boost\" target=\"_blank\">Lululemon +11.5% on beat, buyback, and guidance boost</a> (Dec. 7)</li>          <li>Previously: <a href=\"https://seekingalpha.com/news/3229355-analysts-weigh-lululemon\" target=\"_blank\">Analysts weigh in on Lululemon</a> (Dec. 8)</li>     <li>Shares of LULU are <font color=\"green\">+18.16%</font> to $70.71.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229428\" data-linked=\"Lululemon skyrockets as investors bet on bright future\" data-tweet=\"$LULU - Lululemon skyrockets as investors bet on bright future https://seekingalpha.com/news/3229428-lululemon-skyrockets-investors-bet-on-bright-future?source=tweet\" data-url=\"https://seekingalpha.com/news/3229428-lululemon-skyrockets-investors-bet-on-bright-future\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229426\" data-ts=\"1481210202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGSE\" target=\"_blank\">RGSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229426-rgs-energy-sinks-after-pricing-4_1m-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RGS Energy sinks after pricing $4.1M public offering</a></h4><ul>     <li>RGS Energy (<a href=\"https://seekingalpha.com/symbol/RGSE\" title=\"RGS Energy, Inc.\">RGSE</a> <font color=\"red\">-36.4%</font>) plunges by more than a third after pricing a public offering of common stock and warrants at $0.22/unit, for $4.1M in total proceeds.</li>     <li>Each unit consists of one common share and a warrant  to purchase a common share at an exercise price of $0.35.</li>     <li>RGSE has fallen by more than half since first announcing an offering after Monday's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229426\" data-linked=\"RGS Energy sinks after pricing $4.1M public offering\" data-tweet=\"$RGSE - RGS Energy sinks after pricing $4.1M public offering https://seekingalpha.com/news/3229426-rgs-energy-sinks-after-pricing-4_1m-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3229426-rgs-energy-sinks-after-pricing-4_1m-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229418\" data-ts=\"1481209334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229418-juniper-networks-upgraded-to-buy-nomura-securities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper Networks upgraded to Buy at Nomura Securities</a></h4><ul>\n<li>Moving from Neutral prior, <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/16/12/8785382/junipers-switching-business-strengthening-leads-nomura-t\" target=\"_blank\">analyst Jeffrey Kvaal</a> additionally raises target from $24 to $33 (current price $28.73), particularly highlighting switching unit growth he projects at 12%+ for 2017, roughly double consensus estimates. Increases expectations for FY 2016 EPS to $2.08, from $2.07, and FY 2017 to $2.36, from $2.21.</li>\n<li>Juniper Networks' (<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a> <font color=\"green\">+3.5%</font>) received similar rating change at Credit Suisse yesterday, with <a href=\"http://www.streetinsider.com/Analyst+Comments/Credit+Suisse+Upgrades+Juniper+Networks+%28JNPR%29+to+Outperform/12319407.html\" target=\"_blank\">analyst Kulbinder Garcha</a> upgrading shares off the sidelines to Outperform.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229418\" data-linked=\"Juniper Networks upgraded to Buy at Nomura Securities\" data-tweet=\"$JNPR - Juniper Networks upgraded to Buy at Nomura Securities https://seekingalpha.com/news/3229418-juniper-networks-upgraded-to-buy-nomura-securities?source=tweet\" data-url=\"https://seekingalpha.com/news/3229418-juniper-networks-upgraded-to-buy-nomura-securities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229412\" data-ts=\"1481208090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNT\" target=\"_blank\">VRNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229412-verint-systems-off-focus-list-j-p-morgan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verint Systems off focus list at J.P. Morgan</a></h4><ul>\n<li>Subsequent a <a href=\"https://seekingalpha.com/news/3229232-verint-systems-misses-0_10-misses-revenue\" target=\"_blank\">discouraging Q3 print</a> registered yesterday.</li>\n<li>Verint Systems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VRNT\" title=\"Verint Systems Inc.\">VRNT</a>) is trading <font color=\"red\">nearly 10% lower</font> to $34.60 early.</li>\n<li>\n<em><strong>N.B.</strong></em> Oppenheimer &amp; Co. <a href=\"http://www.streetinsider.com/Analyst+Comments/Verint+Systems+%28VRNT%29%3A+Big+EPS+Miss+But+Hope+For+Improvement+-+Oppenheimer/12324182.html\" target=\"_blank\">maintains at Outperform</a> with a $49 target.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229412\" data-linked=\"Verint Systems off focus list at J.P. Morgan\" data-tweet=\"$VRNT - Verint Systems off focus list at J.P. Morgan https://seekingalpha.com/news/3229412-verint-systems-off-focus-list-j-p-morgan?source=tweet\" data-url=\"https://seekingalpha.com/news/3229412-verint-systems-off-focus-list-j-p-morgan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229408\" data-ts=\"1481207317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229408-cienaplus-7_6-pre-market-q4-earnings-okay-management-commentary-favorable\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena +7.6% pre-market; Q4 earnings okay, management commentary favorable</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3229340-ciena-misses-0_02-revenue-line\" target=\"_blank\">Results</a></strong> \u2013 revenue $716.2M (+3.5% Y/Y, <a href=\"https://finance.yahoo.com/quote/CIEN/analysts?p=CIEN\" target=\"_blank\">consensus $716.48M</a>), EPS $044 (<font color=\"red\">$0.02 below estimat</font><font color=\"red\">es</font>), net income $69.4M (vs. $67.3M Y/Y), gross margin 45.2% (vs. 44.9% Y/Y), operating expense $232.4M (vs. $220.5M Y/Y), operating margin 12.8% (vs. 13% Y/Y)</li>\n<li>\n<strong>Segment revenues</strong> \u2013 Networking platforms $566.2M, Software and Software-Related Services $37.6M, Global Services $112.4M</li>\n<li>\n<strong>Q1 projections</strong> \u2013 revenue $615M-$645M (consensus $634.6M), gross margin mid-40s percentage range, operating expense $220M-$225M</li>\n<li>Ciena (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a>) president and CEO Gary Smith: \"Our strong fiscal 2016 results demonstrate our increasingly differentiated performance versus our competitors, marking Ciena's seventh consecutive year of growing faster than the overall market as well as steady improvement in our operating leverage, profitability and cash flow. We believe that the combination of our leading technology, strategic investments, global scale and business diversification will enable us to continue to take market share and drive operating leverage in fiscal 2017.\"</li>\n<li><a href=\"http://edge.media-server.com/m/p/53mpcbtb/lan/en\" target=\"_blank\"><strong>Conference call</strong></a></li>\n<li><a href=\"https://seekingalpha.com/filing/3318179\" target=\"_blank\">8-K</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229408\" data-linked=\"Ciena +7.6% pre-market; Q4 earnings okay, management commentary favorable\" data-tweet=\"$CIEN - Ciena +7.6% pre-market; Q4 earnings okay, management commentary favorable https://seekingalpha.com/news/3229408-cienaplus-7_6-pre-market-q4-earnings-okay-management-commentary-favorable?source=tweet\" data-url=\"https://seekingalpha.com/news/3229408-cienaplus-7_6-pre-market-q4-earnings-okay-management-commentary-favorable\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229406\" data-ts=\"1481207241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229406-mid-stage-data-on-therapeutic-approach-to-managing-neratinib-associated-diarrhea-shows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mid-stage data on therapeutic approach to managing neratinib-associated diarrhea shows promise, patients on prior pertuzumab therapy still a challenge; Puma Bio shares down 8% premarket</a></h4><ul>\n<li>Puma Biotechnology (NYSE:<a href=\"https://seekingalpha.com/symbol/PBYI\" title=\"Puma Biotechnology, Inc.\">PBYI</a>) slumps <font color=\"red\">8%</font> premarket on light volume in apparent response to its announcement of Phase 2 data on the incidence of diarrhea in breast cancer patients receiving neratinib (PB272). The results were presented at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium.</li>\n<li>Severe (grade 3) diarrhea is the principal adverse event associated with neratinib. In the Phase 3 ExteNET study, 95.4% of participants experienced all-grade diarrhea, almost 40% grade 3 or higher.</li>\n<li>An open-label Phase 2 study, CONTROL, assessed the use of loperamide (branded as Imodium) with and without other agents to prevent or reduce the debilitating side effect. HER2-positive breast cancer patients who had completed adjuvant therapy with trastuzumab (Roche's Herceptin) received neratinib for one year.</li>\n<li>Interim data from 135 subjects who received loperamide prophylaxis showed a rate of grade 3 diarrhea of 28.1%, higher than the 16% rate reported in December 2015. 25 patients (18.5%) discontinued neratinib due to diarrhea.</li>\n<li>In patients who received a combination of loperamide and the corticosteroid budesonide, the incidence of grade 3 diarrhea was 15.0%.</li>\n<li>In patients who received loperamide prophylaxis and were previously treated with pertuzumab (Roche's <a href=\"http://www.perjeta.com/?cid=per_PS_MBPTBC0002&amp;c=MBPTBC0002&amp;mkwid=sj7oOrghc_dc_pcrid_92659290048_pkw_pertuzumab_pmt_e&amp;utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=Patient+Branded+%7C+Perjeta+%7C+P+%7C+Branded+%7C+Perjeta.com+%7C+BC+%7C+per_PS_MBPTBC0002&amp;utm_term=pertuzumab&amp;gclid=CN-U-tvh5NACFQMMaQodDVwKBQ\" target=\"_blank\">PERJETA</a>), the rate of grade 3 diarrhea was 35.2%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229406\" data-linked=\"Mid-stage data on therapeutic approach to managing neratinib-associated diarrhea shows promise, patients on prior pertuzumab therapy still a challenge; Puma Bio shares down 8% premarket\" data-tweet=\"$PBYI - Mid-stage data on therapeutic approach to managing neratinib-associated diarrhea shows promise, patients on prior pertuzumab therapy still a challenge; Puma Bio shares down 8% premarket https://seekingalpha.com/news/3229406-mid-stage-data-on-therapeutic-approach-to-managing-neratinib-associated-diarrhea-shows?source=tweet\" data-url=\"https://seekingalpha.com/news/3229406-mid-stage-data-on-therapeutic-approach-to-managing-neratinib-associated-diarrhea-shows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229405\" data-ts=\"1481206752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLLI\" target=\"_blank\">OLLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229405-ollies-bargain-outlet-falls-back-after-sizzling-2016-run\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ollie&#39;s Bargain Outlet falls back after sizzling 2016 run</a></h4><ul> <li>Ollie's Bargain Outlet Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OLLI\" title=\"Ollie's Bargain Outlet Holdings\">OLLI</a>) trades lower after comparable sales growth missed Q3 estimates, +1.8% vs. +2.1%.</li> <li>\"Given the valuation, run up in the stock into the quarter and the fact that they\u2019ve consistently beat the comp by ~300 bps since going public, not surprised by move lower,\" Buckingham Research analyst Kelly Halsor tells Bloomberg.</li> <li>Ollie's beat profit estimates with its Q3 report after lower transportation and distribution costs helped to lift margins.</li> <li>OLLI <font color=\"red\">-2.98%</font> premarket to $30.90. Shares of OLLI are +87% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229405\" data-linked=\"Ollie&#39;s Bargain Outlet falls back after sizzling 2016 run\" data-tweet=\"$OLLI - Ollie&#39;s Bargain Outlet falls back after sizzling 2016 run https://seekingalpha.com/news/3229405-ollies-bargain-outlet-falls-back-after-sizzling-2016-run?source=tweet\" data-url=\"https://seekingalpha.com/news/3229405-ollies-bargain-outlet-falls-back-after-sizzling-2016-run\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229403\" data-ts=\"1481206681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229403-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='red'>-43%</font>. <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-12%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-6%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/CODI' title='Compass Diversified Holdings'>CODI</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3229403\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$VYGR $TLRD $LULU - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3229403-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3229403-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229390\" data-ts=\"1481205332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHIP\" target=\"_blank\">SHIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229390-seanergy-maritime-prices-15m-offering-shares-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seanergy Maritime prices $15M offering, shares plunge</a></h4><ul> <li>Seanergy Maritime Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHIP\" title=\"Seanergy Maritime Holdings Corp\">SHIP</a>) announces it priced a $15M offering of 10M shares and class A warrants at a combined price of $1.50 per share and class A warrant.</li>\n<li>The offering is expected to close on or about December 13.</li>\n<li>Seanergy estimates that the proceeds from the offering after expenses and fees will be approximately $13.38M.</li>\n<li>The proceeds are slated to be used for debt repayment, vessel acquisitions and general corporate purposes.</li>\n<li>SHIP <font color=\"red\">-45.45%</font> premarket to $1.20.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229390\" data-linked=\"Seanergy Maritime prices $15M offering, shares plunge\" data-tweet=\"$SHIP - Seanergy Maritime prices $15M offering, shares plunge https://seekingalpha.com/news/3229390-seanergy-maritime-prices-15m-offering-shares-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3229390-seanergy-maritime-prices-15m-offering-shares-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229389\" data-ts=\"1481205231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXL\" target=\"_blank\">AVXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229389-anavexs-lead-product-candidate-successful-in-mid-stage-alzheimers-study-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anavex&#39;s lead product candidate successful in mid-stage Alzheimer&#39;s study; shares ahead 8% premarket</a></h4><ul>\n<li>Micro cap Anavex Life Sciences (<a href=\"https://seekingalpha.com/symbol/AVXL\" title=\"Anavex Life Sciences Corp.\">AVXL</a>) perks up <font color=\"green\">8%</font> premarket on increased volume in response to its announcement of positive results from a Phase 2a clinical trial assessing lead product candidate ANAVEX 2-73 in patients with mild-to-moderate Alzheimer's disease (AD). The study met both primary and secondary endpoints.</li>\n<li>No safety signals were observed.</li>\n<li>The data will be presented on December 10 at the Clinical Trials on Alzheimer's Disease meeting. A conference call for investors is also on tap (in conjunction with its fiscal year-end report).</li>\n<li>Orally available <a href=\"http://www.anavex.com/pipeline/anavex-2-73/\" target=\"_blank\">ANAVEX 2-73</a> is a sigma-1 receptor (S1R) agonist. S1Rs play a key role in the modulation of neurotransmission. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229389\" data-linked=\"Anavex&#39;s lead product candidate successful in mid-stage Alzheimer&#39;s study; shares ahead 8% premarket\" data-tweet=\"$AVXL - Anavex&#39;s lead product candidate successful in mid-stage Alzheimer&#39;s study; shares ahead 8% premarket https://seekingalpha.com/news/3229389-anavexs-lead-product-candidate-successful-in-mid-stage-alzheimers-study-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3229389-anavexs-lead-product-candidate-successful-in-mid-stage-alzheimers-study-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229387\" data-ts=\"1481204168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHRP\" target=\"_blank\">OHRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229387-ohr-pharma-prices-equity-offering-shares-down-25-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ohr Pharma prices equity offering; shares down 25% premarket</a></h4><ul>\n<li>Ohr Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OHRP\" title=\"Ohr Pharmaceutical, Inc.\">OHRP</a>) slumps <font color=\"red\">25%</font> premarket on light volume in response to the pricing of its public offering of stock and warrants.</li>\n<li>3.875M common shares, Series A warrants to purchase up to 1,937,500 common shares and Series B warrants to purchase up to 3.875M common shares are being offered at a combined price of $2.00.</li>\n<li>The five-year Series A warrants are exercisable at $2.75 while the six-month Series B warrants are exercisable at $3.00.</li>\n<li>Closing date is December 13.</li>\n<li>Yesterday's close was $2.525.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229387\" data-linked=\"Ohr Pharma prices equity offering; shares down 25% premarket\" data-tweet=\"$OHRP $NBSE - Ohr Pharma prices equity offering; shares down 25% premarket https://seekingalpha.com/news/3229387-ohr-pharma-prices-equity-offering-shares-down-25-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3229387-ohr-pharma-prices-equity-offering-shares-down-25-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229381\" data-ts=\"1481203534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229381-tonix-pharmas-lead-product-candidate-shows-treatment-benefit-in-combat-related-ptsd-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma&#39;s lead product candidate shows treatment benefit in combat-related PTSD; shares up 11% premarket</a></h4><ul>\n<li>Nano cap Tonix Pharmaceuticals Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TNXP\" title=\"Tonix Pharmaceuticals Holding Corp.\">TNXP</a>) perks up <font color=\"green\">11%</font> premarket on increased volume in response to its announcement of positive data from a subgroup of patients in its Phase 2 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02277704?term=TNX-102+SL&amp;rank=4\" target=\"_blank\">AtEase</a>, of lead product candidate TNX-102 SL (cyclobenzaprine HCl sublingual tablets) in military-related post-traumatic stress disorder (PTSD).</li>\n<li>An analysis of participants whose index trauma was directly related to combat (n=197) and who had more pronounced PTSD symptoms as measured by a scale called CAPS-5, treatment with TNX-102 SL (5.6 mg) produced an improvement in total CAPS-5 severity in addition lessening reckless and self-destructive behavior. Functional improvement was also observed.</li>\n<li>Combat-related PTSD is the most difficult to treat.</li>\n<li>The study should be completed by June 2017.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229381\" data-linked=\"Tonix Pharma&#39;s lead product candidate shows treatment benefit in combat-related PTSD; shares up 11% premarket\" data-tweet=\"$TNXP - Tonix Pharma&#39;s lead product candidate shows treatment benefit in combat-related PTSD; shares up 11% premarket https://seekingalpha.com/news/3229381-tonix-pharmas-lead-product-candidate-shows-treatment-benefit-in-combat-related-ptsd-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3229381-tonix-pharmas-lead-product-candidate-shows-treatment-benefit-in-combat-related-ptsd-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229367\" data-ts=\"1481201604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229367-bond-prices-and-dollar-hammered-on-ecb-taper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bond prices and the dollar hammered on ECB taper</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/news/3229366-ecb-leaves-rates-unchanged-sets-taper\" target=\"_blank\">The ECB just </a>announced a slowing of monthly asset purchases to \u20ac60B per month (from \u20ac80B) beginning in April.</li>\n<li>Bond yields are spiking higher in Europe and here, with the 10-year U.S. Treasury yield up six basis points to 2.40%. <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"red\">-1.1%</font>, <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"green\">+2.2%</font>\n</li>\n<li>The dollar index (<a href=\"https://seekingalpha.com/symbol/UUP\" title=\"PowerShares DB USD Bull ETF\">UUP</a>, <a href=\"https://seekingalpha.com/symbol/UDN\" title=\"PowerShares DB USD Bear ETF\">UDN</a>) is <font color=\"red\">down 0.55%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229367\" data-linked=\"Bond prices and the dollar hammered on ECB taper\" data-tweet=\"$TLT $TBT $UUP - Bond prices and the dollar hammered on ECB taper https://seekingalpha.com/news/3229367-bond-prices-and-dollar-hammered-on-ecb-taper?source=tweet\" data-url=\"https://seekingalpha.com/news/3229367-bond-prices-and-dollar-hammered-on-ecb-taper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229364\" data-ts=\"1481201315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIXXF\" target=\"_blank\">AIXXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229364-chinas-fujian-drops-aixtron-bid-after-u-s-blocks-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China&#39;s Fujian drops Aixtron bid after U.S. blocks deal</a></h4><ul>     <li>China's Fujian Grand Chip Investment Fund <a href=\"http://www.reuters.com/article/us-aixtron-m-a-fujian-idUSKBN13X16H\" target=\"_blank\">drops its takeover bid</a> for German chip equipment maker Aixtron (AIXG), saying its offer had lapsed as it had <a href=\"https://seekingalpha.com/news/3228408-aixtron-deal-formally-blocked\" target=\"_blank\">failed to obtain U.S. regulatory approval</a> for the deal.</li>     <li>AIXG's technology is being used to upgrade both U.S. and foreign-owned Patriot missile defense systems, and the U.S. blocked the deal last Friday due to national security risks.</li>\n<li>AIXG <font color=\"red\">-2.6%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229364\" data-linked=\"China&#39;s Fujian drops Aixtron bid after U.S. blocks deal\" data-tweet=\"$AIXXF - China&#39;s Fujian drops Aixtron bid after U.S. blocks deal https://seekingalpha.com/news/3229364-chinas-fujian-drops-aixtron-bid-after-u-s-blocks-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3229364-chinas-fujian-drops-aixtron-bid-after-u-s-blocks-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229355\" data-ts=\"1481199745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229355-analysts-weigh-in-on-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts weigh in on Lululemon</a></h4><ul> <li>Lululemon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a>) soars after a strong Q3 report and positive comments from management on Thanksgiving weekend traffic and e-commerce momentum.</li> <li>The company's scheduled store debut in China this month is also grabbing some attention from analysts.</li> <li>Evercore lifts LULU to a Buy rating and assigns a $80 price target.</li> <li>Mizuho moves the retailer to a Buy rating and $78 PT.</li> <li>Bank of America Merrill Lynch upgrades to Buy with a $70 PT.</li> <li>Stifel Nicolaus sticks with a Neutral rating and raises its PT to $67. The firm is still looking for \"tanglible evidence\" that new concepts and markets can sustain revenue growth.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3229237-lululemon-plus-11_5-percent-beat-buyback-guidance-boost\" target=\"_blank\">Lululemon +11.5% on beat, buyback, and guidance boost</a> (Dec. 7)</li> <li>LULU <font color=\"green\">+15.94%</font> premarket to $69.28.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229355\" data-linked=\"Analysts weigh in on Lululemon\" data-tweet=\"$LULU - Analysts weigh in on Lululemon https://seekingalpha.com/news/3229355-analysts-weigh-in-on-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3229355-analysts-weigh-in-on-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229351\" data-ts=\"1481199215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229351-tailored-brands-soars-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tailored Brands soars after earnings beat</a></h4><ul> <li>Shares of Tailored Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/TLRD\" title=\"Tailored Brands, Inc\">TLRD</a>) soar after the retailer blasts past Q3 estimates.</li> <li>CEO Doug Ewert says cost reduction initiatives led by bottom line improvement.</li> <li>Comparable sales were up 0.1% for the Men's Wearhouse chain and fell 10% at Jos. A. Bank.</li> <li>Retail gross margin improved 161 bps to 45.9% of sales as Tailored Brands lapped last year's anniversary sales.</li> <li>TLRD <font color=\"green\">+24.14%</font> to $23.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229351\" data-linked=\"Tailored Brands soars after earnings beat\" data-tweet=\"$TLRD - Tailored Brands soars after earnings beat https://seekingalpha.com/news/3229351-tailored-brands-soars-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3229351-tailored-brands-soars-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229345\" data-ts=\"1481198720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229345-advanced-micros-big-run-continues-baml-jumps-on-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Micro&#39;s big run continues as BAML  jumps on board</a></h4><ul>\n<li>Advanced Micro Device (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a>) is <font color=\"green\">higher by 3.45%</font> in premarket action as BAML upgrades to Buy with $12 price target (25% upside).</li>\n<li>The stock's more than <font color=\"green\">a three-bagger </font>in 2016.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229345\" data-linked=\"Advanced Micro&#39;s big run continues as BAML  jumps on board\" data-tweet=\"$AMD - Advanced Micro&#39;s big run continues as BAML jumps on board https://seekingalpha.com/news/3229345-advanced-micros-big-run-continues-baml-jumps-on-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3229345-advanced-micros-big-run-continues-baml-jumps-on-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229338\" data-ts=\"1481198218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229338-biodelivery-sciences-up-9-premarket-on-return-of-belbuca-from-endo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences up 9% premarket on return of BELBUCA from Endo</a></h4><ul>\n<li>BioDelivery Sciences International (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BDSI\" title=\"BioDelivery Sciences International, Inc.\">BDSI</a>) is up <font color=\"green\">9%</font> premarket on light volume in response to its announcement that Endo International (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a>) will return global rights to BELBUCA (buprenorphine) buccal film back to BDSI effective January 6, 2017. The product's annual sales run-rate is more than $27M so it will be immediately accretive to revenue and earnings.</li>\n<li>Endo says its remaining portfolio of pain products does not require a field sales force so it is eliminating its 375-person U.S. Branded pain sales organization as well as internal support for the promoted pain business unit. The move will enable it to focus its resources on its core U.S. Branded assets including XIAFLEX (collagenase clostridium histolyticum). It will record a restructuring charge of ~$62M as a result. The initiative is expected to save $90M - 100M in run-rate cost savings next year.</li>\n<li>Endo CEO Paul Campanelli says, \"Since we entered into our licensing and development agreement with BDSI in 2012, the opioid market and Endo's strategic priorities have evolved. While we continue to believe BELBUCA is a differentiated asset, the product no longer aligns with Enod's U.S. Branded segment strategy and our focus on core assets, including XIAFLEX, moving forward.\"</li>\n<li>BDSI will host a conference call this morning at 8:00 am ET to discuss the matter.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229338\" data-linked=\"BioDelivery Sciences up 9% premarket on return of BELBUCA from Endo\" data-tweet=\"$BDSI $BDSI $ENDP - BioDelivery Sciences up 9% premarket on return of BELBUCA from Endo https://seekingalpha.com/news/3229338-biodelivery-sciences-up-9-premarket-on-return-of-belbuca-from-endo?source=tweet\" data-url=\"https://seekingalpha.com/news/3229338-biodelivery-sciences-up-9-premarket-on-return-of-belbuca-from-endo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3229325\" data-ts=\"1481196094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229325-on-sears-holdings-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sears Holdings&#39; Q3</a></h4><ul>     <li>Sears Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHLD\" target=\"_blank\">SHLD</a>) reports comparable-store sales declined 7.4% in Q3.</li>     <li>Kmart comp fell 4.4% due to declines in the grocery &amp; household, consumer electronics and pharmacy categories.</li>     <li>Sears domestic comp down 10%, driven by decreases in the home appliances, apparel and consumer electronics categories.</li>     <li>Segment sales: Kmart: $1.89B (-16%); Sears Domestic: $3.14B (-10.3%).</li>     <li>Gross margin rate decreased 280 bps to 19.1%.</li>     <li>SG&amp;A expense rate expanded 240 bps to 30.7%.</li>     <li>Merchandise inventory -18.9% to $5.03B.</li>     <li>Store count -184 Y/Y to 1,503.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3229325\" data-linked=\"More on Sears Holdings&#39; Q3\" data-tweet=\"$SHLDQ - More on Sears Holdings&#39; Q3 https://seekingalpha.com/news/3229325-on-sears-holdings-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3229325-on-sears-holdings-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":56,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}